Treating Lung Cancer
with Cryoablation

Choose a Minimally Invasive Treatment

At IceCure, we believe in choice for patients with lung cancer*. IceCure’s ProSense Cryoablation System provides a minimally-invasive solution for treating tumors with minimal discomfort and scarring.

Studies show cryoablation for lung cancer is associated with a good overall long-term survival comparable to radiation therapy (stereotactic body radiation therapy (SBRT)) and surgery (sublobar resection) with minimal significant complications 1,2,3.

It’s Your Choice.

1 Palussière J., Catena V. & Buy X. Percutaneous thermal ablation of lung tumors.
2 Moore W. et al. Five-year survival after cryoablation of stage I non-small cell lung cancer.
3 Nomori H. et al. Cryoablation for T1N0M0 non-small cell lung cancer using liquid nitrogen.

*IceCure has regulatory approvals worldwide and clinical indications may vary by region. Please contact us for additional information.

Treating Lung Tumors
with Cryoablation

Choose a Minimally Invasive Treatment

At IceCure, we believe in choice for patients with lung cancer. IceCure’s ProSense Cryoablation System provides a minimally-invasive solution for treating tumors with minimal discomfort and scarring.

Studies show cryoablation for lung cancer is associated with a good overall long-term survival comparable to radiation therapy (stereotactic body radiation therapy (SBRT)) and surgery (sublobar resection) with minimal significant complications 1,2,3.

It’s Your Choice.

1 Palussière J., Catena V. & Buy X. Percutaneous thermal ablation of lung tumors
2 Moore W. et al. Five-year survival after cryoablation of stage I non-small cell lung cancer
3 Nomori H. et al. Cryoablation for T1N0M0 non-small cell lung cancer using liquid nitrogen.

*IceCure has regulatory approvals worldwide and clinical indications may vary by region. Please contact us for additional information.

Choose Results

Published studies found the ProSense single cryoprobe system safe and effective in treating metastatic lung cancers with excellent outcomes and high local lesion control. 

96%

Of patients were cancer free at 3 year follow up for tumors <2 cm in size4*

75%

Of patients were without adverse events including pneumothorax (a collapsed lung)4

45

Minute cryoablation cycle time on average4
 

4 Nomori, H., Yamazaki, I., & Adachi, T. (2022, July). Cryoablation Using Liquid Nitrogen for Metastatic Lung Cancers. Clinics in Oncology, 7, Article 1932.

Testimonials

“In 101 patients with T1N0M0 non-small cell lung cancer (NSCLC), we found that utilizing the Liquid Nitrogen (LN2) based ProSense Cryoablation System to be a promising treatment for tumors <1.8cm in size. Furthermore, LN2 systems have higher power and lower cost when compared to argon gas cryoablation systems.” 

Dr. Hiroaki Nomori,
Kameda Medical Center,
Japan

Choose a Better Treatment Experience

ProSense’s minimally invasive cryoablation procedure provides patients and physicians with an improved treatment experience with minimal pain, reduced scarring, and accelerated recovery.

  • Rapid recovery: One day of hospital stay on average, helping lower hospital costs with some patients able to go home that same day
  • Short procedure: Up to 2 hours for a cryoablation procedure helping save physicians time and reduce waiting times (surgery is typically 2- 6 hours)
  • Minimal pain and discomfort: Cooling from the cryoablation itself reduces pain
  • Can be performed under light sedation: Eliminates risks from general anesthesia required during surgery
  • Works alongside existing chemotherapy, surgical resection, SBRT, or immunotherapy
  • Repeatable procedure: Allows for further treatment and potentially reduces the impact of higher local recurrence after a single ablation
  • Easy to use and efficient: Powerful liquid nitrogen freezing without gas line restrictions, user friendly touch screen system and unique single cryoprobe system helps saves time and cost

Choose Cryoablation for Lung Cancer 

Cryoablation for lung cancer* or benign tumors is a safe and effective minimally invasive procedure providing an additional treatment option to higher-risk surgical interventions or SBRT. Using CT imaging, a specialized cryoprobe (like a thin hollow needle) is guided and inserted into the tumor.  Freezing temperatures are applied that grow an ice ball to engulf the tumor and destroy it leaving healthy tissue unharmed.  

*IceCure has regulatory approvals worldwide and clinical indications may vary by region. Please contact us for additional information.

Resources

Webinars

Webinar: Cryoablation in the Thoracic Cavity

This webinar lead by Dr. Julien Frandon of the Department of Radiology at CHU de Nîmes discusses various cases performed with the ProSense™ Liquid Nitrogen (LN2) Based Cryoablation System in the thoracic cavity (i.e. lung, mediastinum). (60 minutes)

Read More >

Publications

Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions

The aim of this retrospective study was to assess the feasibility of the IceCure’s single-probe liquid nitrogen system for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique.

Read More >

Publications

Cryoablation Using Liquid Nitrogen for Metastatic Lung Cancers

This retrospective observational study conducted by Professor Hiroaki Nomori, MD found that cryoablation using liquid nitrogen would be one of the treatment methods for metastatic lung cancers <2.2 cm; and pulmonary function decreased significantly when cryoablation was performed for an

Read More >